Side Effect Reporting Tool Helps Patients on Chemo Live Longer

Giving patients with cancer the ability to report side effects from chemotherapy right away using an online reporting tool helps them live longer.

Researchers at Memorial Sloan Kettering Cancer Center in New York City randomized 766 patients undergoing chemotherapy for solid tumors to receive either standard care or standard care with patient-reported outcomes (PRO). The latter involved patients self-reporting 12 common chemotherapy side effects – such as constipation, nausea and pain – using a web-based questionnaire both during and in between visits.

When a patient in the latter group reported a symptom that was severe or worsening, an email was sent to a nurse and a report regarding the patient’s symptom history was provided to an oncologist before the next appointment.

Patients in the PRO group had a median overall survival of 5 months longer compared to those just receiving usual care, the researchers reported in JAMA.

Possible reasons for the improved survival in the PRO group, according to researchers, are that clinicians were able to respond to side effects more rapidly in the PRO group, avoiding further problems down the line; nurses were able to intervene with counseling, dose modification or other medications; and patients were able to stay on chemotherapy longer.

A larger trial is underway with 1,000 patients undergoing oncology treatment across the country. The reporting tool being used works on smartphones.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement